These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 16714248)

  • 1. Determinants of risk factors of atherosclerosis in the postinfarction period: the Tallinn MI study.
    Aasvee K; Jauhiainen M; Kurvinen E; Tur I; Sundvall J; Roovere T; Baburin A
    Scand J Clin Lab Invest; 2006; 66(3):191-9. PubMed ID: 16714248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for acute myocardial infarction in Latin America: the INTERHEART Latin American study.
    Lanas F; Avezum A; Bautista LE; Diaz R; Luna M; Islam S; Yusuf S;
    Circulation; 2007 Mar; 115(9):1067-74. PubMed ID: 17339564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of apoE polymorphism with lipoprotein(a), apoA, apoB and lipid levels in atherosclerotic infarct.
    Tascilar N; Dursun A; Ankarali H; Mungan G; Sumbuloglu V; Ekem S; Bozdogan S; Baris S; Aciman E; Cabuk F
    J Neurol Sci; 2009 Feb; 277(1-2):17-21. PubMed ID: 18945448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasma level of Lp(a) in patients with myocardial infarct is not controlled by the apolipoprotein E gene polymorphism].
    Hubácek JA; Stávek P; Pit'ha J; Skodová Z; Poledne R
    Cas Lek Cesk; 2001 Jun; 140(11):332-4. PubMed ID: 11431852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lipoprotein(a): genetic marker of precocious myocardial infarction].
    Guazzelli R; Fatini C; Piazzini M; Lazzeri C
    Ann Ital Med Int; 1996; 11(2):90-4. PubMed ID: 8974444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between apolipoprotein E gene polymorphism and plasminogen activator inhibitor-1 and atherogenic lipid profile in dialysis patients.
    Arikan H; Koc M; Sari H; Tuglular S; Ozener C; Akoglu E
    Ren Fail; 2007; 29(6):713-9. PubMed ID: 17763167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of cholesteryl ester transfer protein, peroxisome proliferator-activated receptor alpha, apolipoprotein E, and apolipoprotein A-I polymorphisms on high-density lipoprotein cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I:A-II concentrations: the Prospective Epidemiological Study of Myocardial Infarction study.
    Do HQ; Nazih H; Luc G; Arveiler D; Ferrières J; Evans A; Amouyel P; Cambien F; Ducimetière P; Bard JM
    Metabolism; 2009 Mar; 58(3):283-9. PubMed ID: 19217440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum lipid and apolipoprotein profiles in newborns and six-year-old children: the Tallinn Young Family Study.
    Kurvinen E; Aasvee K; Zordania R; Jauhiainen M; Sundvall J
    Scand J Clin Lab Invest; 2005; 65(7):541-50. PubMed ID: 16271985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein (a) as a determinant of arterial stiffness in elderly patients with type 2 diabetes mellitus.
    Wakabayashi I; Masuda H
    Clin Chim Acta; 2006 Nov; 373(1-2):127-31. PubMed ID: 16820145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study.
    Kiechl S; Willeit J; Mayr M; Viehweider B; Oberhollenzer M; Kronenberg F; Wiedermann CJ; Oberthaler S; Xu Q; Witztum JL; Tsimikas S
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1788-95. PubMed ID: 17541022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence.
    Walldius G; Jungner I
    J Intern Med; 2006 May; 259(5):493-519. PubMed ID: 16629855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of apolipoprotein E gene polymorphism with ischemic stroke involving large-vessel disease and its relation to serum lipid levels.
    Saidi S; Slamia LB; Ammou SB; Mahjoub T; Almawi WY
    J Stroke Cerebrovasc Dis; 2007; 16(4):160-6. PubMed ID: 17689412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dyslipidemia-related risk factors for myocardial infarction and polymorphism of ApoE gene among myocardial infarction patients and their siblings].
    Bai X; Zhao M; Wang B
    Zhonghua Yi Xue Za Zhi; 2001 Mar; 81(6):340-3. PubMed ID: 11798896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Coronary heart disease risk factors in Croatia and worldwide: results of the Interheart study].
    Carević V; Rumboldt M; Rumboldt Z;
    Acta Med Croatica; 2007 Jun; 61(3):299-306. PubMed ID: 17629106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid profile in Portuguese obese children and adolescents: interaction of apolipoprotein E polymorphism with adiponectin levels.
    Nascimento H; Silva L; Lourenço P; Weinfurterová R; Castro E; Rego C; Ferreira H; Guerra A; Quintanilha A; Santos-Silva A; Belo L
    Arch Pediatr Adolesc Med; 2009 Nov; 163(11):1030-6. PubMed ID: 19884594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonfatal acute myocardial infarction in Costa Rica: modifiable risk factors, population-attributable risks, and adherence to dietary guidelines.
    Kabagambe EK; Baylin A; Campos H
    Circulation; 2007 Mar; 115(9):1075-81. PubMed ID: 17339565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knowledge of cardiovascular risk factors and awareness of non-pharmacological approach for risk prevention in young survivors of acute myocardial infarction. The cardiovascular risk prevention project "Help Your Heart Stay Young".
    Migliaresi P; Celentano A; Palmieri V; Pezzullo S; Martino S; Bonito M; Guillaro B; Brancati C; Di Minno G
    Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):468-72. PubMed ID: 17379491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of age, the apolipoprotein B/apolipoprotein A-I ratio, and the risk of fatal myocardial infarction and implications for the primary prevention of cardiovascular disease.
    Sniderman AD; Holme I; Aastveit A; Furberg C; Walldius G; Jungner I
    Am J Cardiol; 2007 Jul; 100(2):217-21. PubMed ID: 17631073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Waist circumference adds to the variance in plasma C-reactive protein levels in elderly patients with metabolic syndrome.
    Dupuy AM; Jaussent I; Lacroux A; Durant R; Cristol JP; Delcourt C
    Gerontology; 2007; 53(6):329-39. PubMed ID: 17551260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Childhood levels of serum apolipoproteins B and A-I predict carotid intima-media thickness and brachial endothelial function in adulthood: the cardiovascular risk in young Finns study.
    Juonala M; Viikari JS; Kähönen M; Solakivi T; Helenius H; Jula A; Marniemi J; Taittonen L; Laitinen T; Nikkari T; Raitakari OT
    J Am Coll Cardiol; 2008 Jul; 52(4):293-9. PubMed ID: 18634985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.